Status | Study |
Recruiting |
Study Name: Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Condition: Opsoclonus Myoclonus Syndrome Neuroblastoma Date: 2013-05-27 Interventions: Drug: Dexamethasone acetate |
Completed |
Study Name: Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome Condition: Opsoclonus-myoclonus Syndrome Date: 2008-12-08 |
Completed |
Study Name: Effectiveness of Rituximab in Pediatric OMS Patients. Condition: Opsoclonus-myoclonus Syndrome Opsoclonus Date: 2005-10-24 Interventions: Drug: rituximab |
Completed |
Study Name: Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma Condition: Neuroblastoma Opsoclonus-Myoclonus Date: 2005-09-12 Interventions: Drug: anti-CD20 (Rituximab) |
Completed |
Study Name: Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Condition: Disseminated Neuroblastoma Localized Resectable Neuroblastoma Date: 2002-04-09 Interventions: Biological: therapeutic immune globulin |